---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-26-002142"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2026-04-24T23:59:59+00:00"
generated_at: "2026-05-15T04:16:25.796471+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma receives Nasdaq bid price deficiency notice; expands ATM to $50M

## Summary
- Nasdaq notified Medicus on April 21, 2026 that its stock bid price closed below $1.00 for 30 consecutive business days, non-compliant with Listing Rule 5550(a)(2).
- Company has 180 days (until Oct 19, 2026) to regain compliance by closing at $1.00+ for 10 consecutive days.
- Medicus increased ATM offering amount from ~$15.35M to $50M via Amendment No. 1; ~$11.5M already raised under the program.

## SEC filing metadata
- accession: 0001062993-26-002142
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2026-04-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299326002142/0001062993-26-002142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299326002142/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-26-002142
- JSON: https://secwatch.observer/filing/0001062993-26-002142.json
- Plain text: https://secwatch.observer/filing/0001062993-26-002142.txt

## Key facts
- Listing & Compliance Notices
  Medicus Pharma Ltd. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: April 21, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that the closing bid price for the Company's
  evidence_url: https://www.sec.gov/Archives/edgar/data/1997296/000106299326002142/0001062993-26-002142-index.htm
- Material Agreements
  Medicus Pharma Ltd. amended Equity Distribution Agreement with Maxim Group LLC and Yorkville Securities, LLC valued at up to $50,000,000 (effective 2026-04-23).
  - Action: amendment
  - Agreement: atm program
  - Counterparty: Maxim Group LLC and Yorkville Securities, LLC
  - Value: up to $50,000,000
  - Effective: 2026-04-23
  source text: the Company and the Agents entered into Amendment No. 1 to the Agreement (the "First Amendment", and together with the Agreement, the "Amended Agreement"), pursuant to which the Company increased the size of the aggregate offering amount from $15,349,674 to up to $50,000,000 (the "ATM Upsize")
  evidence_url: https://www.sec.gov/Archives/edgar/data/1997296/000106299326002142/0001062993-26-002142-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.